{"id":"W2979704099","doi":"10.1182/blood.v118.21.2936.2936","title":"Lenalidomide (Revlimid), Bortezomib (Velcade) and Dexamethasone (RVD) for Heavily Pretreated Relapsed or Refractory Multiple Myeloma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Internal medicine; Bortezomib; Regimen; Multiple myeloma; Dexamethasone; Refractory (planetary science); Neutropenia; Oncology; Progression-free survival; Thalidomide; Toxicity; Gastroenterology; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005581995,0.0001340451,0.0003208717,0.0005343102,0.0002031178,0.0003070242,0.0002373529,0.000163175,0.001095356],"category_scores_gemma":[0.001084254,0.0001451843,0.0003218401,0.000555772,0.0001790695,0.0001971224,0.0002331154,0.0002475145,0.0002660423],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002942875,"about_ca_system_score_gemma":0.000305133,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007381749,"about_ca_topic_score_gemma":0.001860615,"domain_scores_codex":[0.9997588,0.00008565492,0.00003920125,0.00003146108,0.00005764431,0.00002715295],"domain_scores_gemma":[0.9990569,0.0003573892,0.0003851574,0.00005021369,0.00004842913,0.0001018592],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.002933035,0.0001449266,0.9511486,0.0001653919,0.0001242227,0.001432084,0.00007556153,0.0004166861,0.003936709,0.00004936352,0.000695231,0.03887823],"study_design_scores_gemma":[0.0002722149,0.003924454,0.9816809,0.0000600173,0.0001498481,0.006122056,0.00007338879,0.002206251,0.001872368,0.00007398732,0.003555605,0.000008890708],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995914,0.00220521,0.0003551258,0.00009727479,0.000007998222,0.00006144313,0.0006898378,0.0000162226,0.0006528887],"genre_scores_gemma":[0.9976124,0.0007920549,0.0003344893,0.00005192348,0.00002575382,0.00002604858,0.000790598,0.000003507217,0.0003631999],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001095356,"threshold_uncertainty_score":0.003664315,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07568505293985034,"score_gpt":0.3070002022097278,"score_spread":0.2313151492698775,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}